Atorvastatin for Prevention of Atrial Fibrillation Recurrence Following Pulmonary Veins Isolation: A Double-Blind, Placebo-Controlled, Randomized Pilot Trial.
Latest Information Update: 10 Nov 2021
Price :
$35 *
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms ATTAC
- 27 Jul 2012 Actual end date (1 Dec 2011) added as reported by ClinicalTrials.gov record.
- 27 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Feb 2012 Results published in the Heart Rhythm.